Loading...
An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma
Targeted therapies have introduced a paradigm shift in the management of metastatic renal cell carcinoma. Currently, four molecules (sunitinib, pazopanib, bevacizumab plus interferon, temsirolimus) are considered in first-line therapy, and three other molecules for second, or subsequent lines of the...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3607488/ https://ncbi.nlm.nih.gov/pubmed/23554847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287212466128 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|